decompensated
美 
英
例句
Cirrhosis is usually described as compensated in its early stages and decompensated as liver failure develops.
肝硬化在早期階段為代償性，發展到肝衰竭階段為失代償。
All patients developed decompensated liver disease despite one patient having had a prior liver biopsy showing absence of cirrhosis.
所有的病人發展為失代償性肝病，盡管其中一位經肝活檢證實沒有形成肝硬化。
Exogenous brain natriuretic peptide can significantly improve acute decompensated heart failure symptoms, related drugs already available.
外源性的腦鈉肽可以顯著改善急性失代償性心力衰竭的癥狀，已有相關藥物問世。
Hepatology Digest: What advances in pharmacological treatment can halt progression to decompensated cirrhosis or reverse cirrhosis?
《國際肝病》：目前對于阻止失代償肝硬化進展或逆轉肝硬化有哪些藥物治療進展？
The radical technique of treatment of the liver decompensated cirrhosis involves transplantation of liver.
肝硬化失代償期肝病治療技術涉及根治肝移植。
There was significant difference of TBA between the patients with compensated and those with decompensated cirrhosis (P0. 01).
肝硬化失代償期患者的TBA水準顯著高于代償期患者（P0。01）。
Conclusions High HBV DNA level in patients with decompensated liver cirrhosis of hepatitis B may have effect on the decrease of PLT.
結論乙型肝炎肝硬化失代償期患者高載量HBVDNA對血小板參數降低有一定的影響。
abstract: Objective: To explore clinical efficacy of Adefovir Dipivoxil in treatment of hepatitis B related decompensated cirrhosis.
目的：探討阿德福韋酯治療失代償乙肝肝硬化的臨床療效。
contributed to the decreased incidence of decompensated liver disease.
促進了失代償性疾病的發病率下降。
Acute decompensated heart failure is a growing public health care problem worldwide.
急性失代償性心力衰竭日益公共保健問題全世界。
Recombined BNP is effective in cases of decompensated heart failure.
此外，重組腦鈉肽對于失代償性心力衰竭的療效顯著。
About 73% had no cirrhosis, 24% had compensated cirrhosis, and 2% had decompensated cirrhosis at baseline.
約73%的人沒有肝硬化，24%有代償性肝硬化，失代償期在基線和2%肝硬化。
However, if you have advanced pre-decompensated cirrhosis, I don't think a biopsy is the best test.
但是，如果是晚期失代償前肝硬化，那么我不認為活檢是最好的檢驗手段。
Methods A retrospective analysis was made in 67 cases with decompensated cirrhosis suffered from the pulmonary infection.
方法對67例失代償肝硬化并發肺部感染患者的臨床資料進行了回顧性分析。
The 12-month all-cause mortality was 27. 4%, and was higher among those with decompensated congestive HF (33. 5%) than the denovo HF group.
12個月的全因死亡率為27.4%，并且失代償性充血性心力衰竭組（33.5%）高于新發心衰組。
Clinical study of Lamivudine treatment in patients with decompensated cirrhosis
拉米夫定在失代償期肝硬化的臨床應用研究
Clinical characteristics of traditional Chinese medical type of syndrome of hepatocirrhosis decompensated period patients
肝炎肝硬化失代償期患者中醫證型臨床特點分析
Multi-interventional therapy for hepatocellular carcinoma with decompensated hepatic cirrhosis
伴失代償肝硬化的肝癌患者綜合介入治療
Clinical Study of Chinese Plus Western Medication in the Treatment of Decompensated Cirrhosis
中西藥聯用治療失代償肝硬變臨床研究
Diagnosis of subclinical hepatic encephalopathy with evoked potentials in patients with decompensated hepatic cirrhosis
誘發電位檢測在失代償期肝硬化患者亞臨床肝性腦病診斷中的價值
Correlation between B-natriuretic peptide and hemodynamics in patients with decompensated heart failure and clinical significance
心力衰竭患者腦利鈉肽濃度與血流動力學的關系及臨床意義
Effects of Lyophilized Recombinant Human Brain Natriuretic Peptide on Heart Rate Variability in Acute Decompensated Heart Failure
新活素對急性心衰患者心率變異性的影響
Clinical significance of peritoneal and retroperitoneal edema in patients with decompensated cirrhosis as demonstrated by CT scan
失代償期肝硬化CT顯示腹膜和腹膜后組織水腫的臨床意義
Clinical Characteristics of Patients with Decompensated Cirrhosis and Concomitant Septic Shock
失代償性肝硬化患者感染性休克的臨床特征分析
Study on catheter lock solutions for maintenance of peripheral intravenous locks in patients with decompensated cirrhosis
肝硬化失代償期病人靜脈留置針封管液的探討
Analysis of factors associated with prognosis in decompensated hepatic cirrhosis patients
失代償期肝炎肝硬化患者的預后相關因素分析
Clinical effects of recombinant human growth hormone in patients with decompensated liver cirrhosis
重組人生長激素治療失代償性肝硬化臨床研究
Establishment of Decompensated Cirrhotic Rat Model Complicated with Ascites
改良的肝硬化門脈高壓伴腹水大鼠模型
Sodium metabolic disorder in decompensated cirrhosis patients and prognosis
失代償期肝硬化患者鈉代謝紊亂及其預后
A retrospective study of 42 death cases with decompensated hepatocirrhosis
42例肝硬化失代償期死亡病例回顧性分析
Expression of ghrelin in gastric mucosa and serum ghrelin level in patients with decompensated cirrhosis
失代償期肝硬化患者胃粘膜和血漿ghrelin改變及其臨床意義
Analysis of prognosis of patients with decompensated liver cirrhosis using the criterion of the Model of End-Stage Liver Disease
失代償期肝硬化患者的終末期肝病模型預后分析
Effect of Simvastatin on Myocardial Oxidative Stress during Decompensated Right Heart Failure in Rats
辛伐他汀對失代償右心衰竭大鼠心肌氧化應激的影響
Managing Acute Decompensated Heart Failure: A Clinician's Guide to Diagnosis and Treatment
急性代償失調性心衰：診斷與治療臨床醫師指南
Clinical values of anti-virus treatment on decompensated cirrhosis patients
失代償期肝硬化抗病毒治療的臨床價值
Effect of anti-endotoxin therapy on vaso-active substances in decompensated liver cirrhosis
抗內毒素治療對肝硬化患者血管活性物質的影響
CT Findings of Edema of Colon and Peritoneum in Patients with Decompensated Cirrhosis
失代償期肝硬化結腸和腹膜水腫的CT表現
Nesiritide: a safe and effective agent for acute decompensated heart failure
治療急性失代償性心力衰竭新藥奈西立肽
Prognosis analysis of patients with decompensated liver cirrhosis using the model of end-stage liver disease
終末期肝病模型對失代償期肝硬化患者預后的回顧性分析
progress in treatment of decompensated heart failure
失代償性心衰治療研究進行時
